This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Junichi Tajiri, MD
Kumamoto, Japan

Shiro Noguchi, MD; Nobuo Murakami, MD
Beppu, Oita, Japan

Arch Intern Med. 1993;153(24):2797.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In their comment, Sobel and Glick stated that the fact we were able to accumulate three patients with agranulocytosis in 1 year is somewhat surprising. We treated 1356 patients with Graves' disease while our granulocyte colony—stimulating factor study was carried out from July 1990 to August 1991. The incidence of antithyroid drug-induced agranulocytosis (granulocyte count, <0.5x10⁹/L) was 0.4% (six of 1356), which was the same as that (0.2% to 0.5%) reported previously.¹ Noguchi Thyroid Clinic (Beppu, Japan) is a special hospital for thyroid disease. About 1200 patients with Graves' disease per year visited this clinic from western Japan. As reported in our article,² from 1975 to 1987, 15 398 patients with Graves' disease were treated with an antithyroid drug in the Noguchi Thyroid Clinic. Of these, 55 (0.4%) were found to have agranulocytosis. We do not think that there is a discrepancy between our data and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?